Positive allosteric γ‐aminobutyric acid type A receptor modulation prevents lipotoxicity‐induced injury in hepatocytes <i>in vitro</i>-Reference-Cited by-同舟云学术

Positive allosteric γ‐aminobutyric acid type A receptor modulation prevents lipotoxicity‐induced injury in hepatocytes in vitro

Published:2022-06-06 Issue:8 Volume:24 Page:1498-1508
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Rohbeck Elisabeth¹^ORCID,Hasse Birgit²,Koopmans Guido²,Romero Alejandra¹^ORCID,Belgardt Bengt‐Frederik³⁴^ORCID,Roden Michael¹⁴⁵^ORCID,Eckel Jürgen¹^ORCID,Romacho Tania¹^ORCID

Affiliation:

1. Institute for Clinical Diabetology, German Diabetes Center Leibniz Center for Diabetes Research at Heinrich‐Heine‐University Düsseldorf Düsseldorf Germany

2. Algiax Pharmaceuticals GmbH Erkrath Germany

3. Institute for Vascular and Islet Cell Biology German Diabetes Center at Heinrich Heine University, Leibniz Center for Diabetes Research Düsseldorf Germany

4. German Center for Diabetes Research (DZD) Partner Düsseldorf München‐Neuherberg Germany

5. Department of Endocrinology and Diabetology, Medical Faculty and University Hospital Düsseldorf Heinrich‐Heine‐University Düsseldorf Düsseldorf Germany

Funder

Bundesministerium für Gesundheit

Fundación Alfonso Martín Escudero

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14719

Reference49 articles.

1. The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments

2. EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

3. Preparing for the NASH Epidemic: A Call to Action

4. Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial

5. Metabolic liver disease in diabetes – From mechanisms to clinical trials

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing of the analgesic Neurotropin for MASLD/MASH treatment;Hepatology Communications;2024-07-18

2. Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): Recent advances;Progress in Lipid Research;2023-07

3. Positive allosteric GABAA receptor modulation counteracts lipotoxicity-induced gene expression changes in hepatocytes in vitro;Frontiers in Physiology;2023-02-13